Correlation Between Transcode Therapeutics and Day One
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Transcode Therapeutics and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Day One.
Diversification Opportunities for Transcode Therapeutics and Day One
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Transcode and Day is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Day One go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and Day One
Given the investment horizon of 90 days Transcode Therapeutics is expected to under-perform the Day One. In addition to that, Transcode Therapeutics is 2.31 times more volatile than Day One Biopharmaceuticals. It trades about -0.23 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 1,447 in Day One Biopharmaceuticals on August 31, 2024 and sell it today you would lose (75.00) from holding Day One Biopharmaceuticals or give up 5.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Transcode Therapeutics vs. Day One Biopharmaceuticals
Performance |
| Timeline |
| Transcode Therapeutics |
| Day One Biopharmaceu |
Transcode Therapeutics and Day One Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transcode Therapeutics and Day One
The main advantage of trading using opposite Transcode Therapeutics and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |